Eli Lilly issues $6.5B of notes across 6 tranches; net proceeds ~$6.46B

ELI LILLY & Co

Issues $1B 4.550% notes due 2028, $1.25B 4.750% notes due 2030, $1B 4.900% notes due 2032.
Issues $1.25B 5.100% notes due 2035, $1.25B 5.500% notes due 2055, $750M 5.600% notes due 2065.
Net proceeds of approximately $6.46B after underwriting discounts; offering closed February 12, 2025.
Notes issued under existing indenture; redemption at company's option on specified terms.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.